Dr Reddy's to enhance presence in emerging segments like nutraceuticals, gene therapy

Dr Reddy's Laboratories plans to expand its presence in nutraceuticals, cell and gene therapy and new chemical entities, as well as exploring integrated digital healthcare services, digital therapeutics and disease management, according to its annual report. The pharmaceuticals firm also stated that increases in access to medicines was a driving philosophy, with efficient and effective operations, processes and practices being key to future productivity.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news